Skip to content
Off-topic for aiqbench

Off-topic for aiqbench

This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.

argenx stops Phase 3 UNITY trial of efgartigimod in Sjögren's disease

Dealroom.co1 min read

argenx stops Phase 3 UNITY trial of efgartigimod in Sjögren's disease  Dealroom

Read the full article at Dealroom.co

Related coverage